SCHEMBL23770613

SCHEMBL23770613

Nc1cc(SNc2ccc(Cl)c(-c3ccccc3C(F)(F)F)n2)ccn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.37
CYP3A4 P08684 6/20 0.37
CYP2C19 P33261 5/20 0.37
ALDH1A1 P00352 1/20 0.37
PTPN1 P18031 4/20 0.36
TRPA1 O75762 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.35
TRPV1 Q8NER1 1/20 0.35
CYP2D6 P10635 3/20 0.34
CYP2C9 P11712 3/20 0.34
TSHR P16473 3/20 0.34
HSD17B10 Q99714 2/20 0.34
BACE1 P56817 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CDC7 O00311 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
DBF4 Q9UBU7 1/20 0.34
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770404 0.90 JAK2 (0.32)
SCHEMBL23770695 0.84 CYP1A2 (0.34) CYP1A2CYP3A4CYP2C19ALDH1A1CYP2D6
SCHEMBL23770732 0.81 NOS3 (0.38) ALDH1A1LMNAS1PR1GLA
SCHEMBL23770756 0.80 BACE1 (0.36) CYP1A2CYP3A4CYP2C19ALDH1A1PTPN1
SCHEMBL19927808 0.78 SCN9A (0.41) ALDH1A1PTPN1TSHRLMNA
SCHEMBL29464553 0.78 SCN9A (0.41) ALDH1A1PTPN1TSHRLMNA
SCHEMBL23770776 0.77 ABL1 (0.38)
SCHEMBL23770552 0.77 JAK2 (0.33) MEN1KMT2A
SCHEMBL23770543 0.77 S1PR1 (0.35) CYP1A2CYP3A4CYP2C19PTPN1CYP2D6
SCHEMBL23770407 0.76 ADORA2A (0.35) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed